Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2015
Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug InteractionsAttarat Pattanawongsa, Nuy Chau, Andrew Rowland, et al.
Molecular Pharmacology|October 3, 2020
Arginine-259 of UGT2B7 Confers UDP-Sugar SelectivityPramod C Nair, Nuy Chau, Ross A McKinnon, et al.
Biochemical Pharmacology|August 25, 2019
Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202Porntipa Korprasertthaworn, Nuy Chau, Pramod C Nair, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 14, 2018
Drug and Chemical Glucosidation by Control Supersomes and Membranes from Spodoptera frugiperda (Sf) 9 Cells: Implications for the Apparent Glucuronidation of Xenobiotics by UDP-glucuronosyltransferase 1A5Nuy Chau, Leyla Kaya, Benjamin C Lewis, et al.
The Journal of Biological Chemistry|October 22, 2023
The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidationPramod C Nair, Kushari Burns, Nuy Chau, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 10, 2011
Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidationVerawan Uchaipichat, Pritsana Raungrut, Nuy Chau, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 15, 2010
Marked reduction in obstructive sleep apnea severity in slow wave sleepRajeev Ratnavadivel, Nuy Chau, Daniel Stadler, et al.
British Journal of Clinical Pharmacology|January 26, 2016
Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearanceKathleen M Knights, Shane M Spencer, John K Fallon, et al.
Molecular Pharmacology|November 20, 2010
The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distributionPeter I MacKenzie, Anne Rogers, David J Elliot, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 25, 2014
Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studiesNuy Chau, David J Elliot, Benjamin C Lewis, et al.
Pageof 2